REFERENCES
- Efremov GD, Duma H, Ruvidic R, Rolovic Z, Wilson JB, Huisman THJ. Hemoglobin Beograd or α2β2121Glu→Val (GH4). Biochim Biophys Acta 1973; 328(1)81–83
- Ruvidic R, Efremov GD, Juricic D, Rolovic Z, Ruzdic I, Pendic S. Hemoglobin Beograd (α2β2121 Glu→Val) interacting with β thalassemia. Acta Haematol 1975; 54(3)180–187
- Oberiter V, Bajanic D, Efremov GD, Huisman THJ. Hb Beograd [α2β2121(GH4)Glu→Val] observed in a new Yugoslavian family. Hemoglobin 1978; 2(5)453–455
- Aksoy M, Kutlar A, Kutlar F, Dincol G, Erdem S, Wilson JB, Huisman THJ. Hb Beograd-β0thalassemia in a Turkish family from Yugoslavia. Hemoglobin 1984; 8(4)417–421
- Wilkinson T. Hemoglobinopathies in Australia and New Zealand. Hemoglobin 1981; 5(5)525–530
- Arcasoy A. Hemoglobinopathies in Turkey. Proceedings of the 5th Meeting of the Mediterranean Blood Club, Antalya, Turkey. 1990; MBC-10(44)
- Akar E, Tunc S, Arcasoy A, Öztürk A, Akar N. Further observation of Hemoglobin Beograd (β121 Glu→Val) in Turkish population. Turk J Hematol 2004; 21(3)149–151
- Atalay EÖ, Koyuncu H, Turgut B, Atalay A, Yildiz S, Bahadir A, Köseler A. High incidence of Hb D-Los Angeles [β121(GH4)Glu→Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin 2005; 29(4)307–310
- British Committee for Standards in Haematology. Guideline: The laboratory diagnosis of haemoglobinopathies. Br J Haematol 1998; 101(4)783–792
- Akar N, Akar E, Tastan H. Feasibility of restriction enzyme protocols for the molecular diagnosis of abnormal hemoglobins in Turkish population. Am J Hematol 1999; 62(3)198–200
- Efremov GD. Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin 2007; 31(1)1–15